You are here

  • Home
  • Archive
  • Volume 6, Issue 10
  • Safety and immunogenicity of a new 13-valent pneumococcal conjugate vaccine versus a licensed 7-valent pneumococcal conjugate vaccine: a study protocol of a randomised non-inferiority trial in China

Citation Tools

Article menu

Download PDFPDF

XML
Immunology (including allergy)
Protocol
Safety and immunogenicity of a new 13-valent pneumococcal conjugate vaccine versus a licensed 7-valent pneumococcal conjugate vaccine: a study protocol of a randomised non-inferiority trial in China

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Chen JJ, Yuan L, Huang Z, et al
Safety and immunogenicity of a new 13-valent pneumococcal conjugate vaccine versus a licensed 7-valent pneumococcal conjugate vaccine: a study protocol of a randomised non-inferiority trial in China
BMJ Open 2016;6:e012488. doi: 10.1136/bmjopen-2016-012488